Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn Phase 2 Interventional

A Study to Investigate Leramistat in Patients With IPF

ClinicalTrials.gov ID: NCT05951296

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT05951296. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 19, 2026, 3:04 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Investigate the Efficacy and Safety of Leramistat in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare the effect of daily oral dosing of leramistat over 12 weeks with placebo in participants aged 40 years or older with idiopathic pulmonary fibrosis (IPF).

Study identification

NCT ID
NCT05951296
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 2
Lead sponsor
Modern Biosciences Ltd
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 30, 2023 (Actual)
Primary completion
Feb 27, 2024 (Actual)
Completion
Mar 14, 2024 (Actual)
Last update posted
Apr 9, 2025

2023 – 2024

United States locations

U.S. sites
21
U.S. states
13
U.S. cities
17
Facility City State ZIP Site status
UCSF Fresno Fresno California 93701-2302 —
National Jewish Health Main Campus Denver Colorado 80206-2761 —
MedStar Georgetown University Hospital Washington D.C. District of Columbia 20007 —
Reliant Medical Research Miami Florida 33165 —
US Associates in Research Inc Miami Florida 33175 —
GCP Clinical Research, LLC Tampa Florida 33609-3589 —
GCP Clinical Research Tampa Florida 33609-3589 —
Southern Medical Research, LLC Macon Georgia 31201-8334 —
GenHarp Clinical Solutions Chicago Illinois 60649-4718 —
IU Health Ball Memorial Physicians Pulmonary and Critical Care Medicine Muncie Indiana 47303-3432 —
Benchmark Research - Covington - HyperCore - PPDS Covington Louisiana 70433-2353 —
University of Maryland Medical Center Baltimore Maryland 21201-1544 —
Howard County Center for Lung and Sleep Medicine, LLC Columbia Maryland 21044-3081 —
Howard County Center for Lung and Sleep Medicine, LLC Columbia Maryland 21045-5422 —
Hudson County Clinical Trials Research Center Union City New Jersey 07087-3375 —
Duke University Medical Center Durham North Carolina 27710-4000 —
Southeastern Research Center Winston-Salem North Carolina 27103-4029 —
Baylor Scott and White Health - Advanced Lung Disease Specialists - Dallas Dallas Texas 75246-2073 —
Metroplex Pulmonary and Sleep Medicine Center-4833 Medical Center Dr McKinney Texas 75069-1898 —
Metroplex Pulmonary and Sleep Medicine Centre 4833 Medical Center Dr McKinney Texas 75069-1898 —
University of Utah - PPDS Salt Lake City Utah 84108-1257 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05951296, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 9, 2025 · Synced Nov 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.